bronchial asthma
Conditions
Interventions
None listed
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: 1. Patients with poorly controlled asthma undergoing outpatient treatment who use an asthma management app during the period from April 1, 2025, to December 31, 2026 2. Patients aged 18 years or older 3. Patients who can provide informed consent to participate in the trial of their own free will
Exclusion criteria
Exclusion criteria: 1. Patients who declined to participate in this study 2. Patients deemed unsuitable for this study by the principal investigator 3. Patients participating in other drug or medical device clinical trials 3. Patients participating in other clinical trials of pharmaceuticals or medical devices
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| To clarify the impact of monitoring app input frequency and medication adherence on the rate of intermittent oral steroid use. | — |
Secondary
| Measure | Time frame |
|---|---|
| Clarify the impact of app input frequency and medication adherence monitoring on disease exacerbation. Clarify the impact of app input frequency and medication adherence monitoring on ACT scores. Clarify the impact of app input frequency and medication adherence monitoring on AHQ-33 JAPAN scores. Determine the impact of app input frequency and medication adherence monitoring on emergency/out-of-hours visits. Determine the relationship between app input frequency and medication adherence monitoring and free comments. Determine the impact of the app and each medication type (biological agents, inhaled medications). | — |
Countries
Japan
Contacts
Hyogo Medical University Hospital Respiratory and Hematology